RT @ECDC_EU: Today is the #WorldTuberculosisDay!
And we are starting it with a presentation of the latest data on #TB!
Follow #ECDCPressConference on YouTube #LIVE at 11:30AM: https://consent.youtube.com/ml?continue=https://www.youtube.com/live/pmVnTeqLgIM?cbrd%3D1&gl=FI&hl=fi&cm=2&pc=yt&src=1
#WorldTBDay2023 #WTB2023 #WorldTBDay
🐦🔗: https://n.respublicae.eu/EMA_News/status/1639219375357009921
RT @EU_HaDEA: Today marks #WorldTuberculosisDay 📅
Around 55 000 cases of tuberculosis are reported annually.
The @EU_Commission is funding projects and initiatives working to tackle this infectious disease.
Find out some examples in this thread ⤵
🐦🔗: https://n.respublicae.eu/EMA_News/status/1639186186563362817
RT @HardemanHildeML: #Artificialintelligence is around us ever more. It’s shaping how we do things and how we get our information. It holds much potential for industry, services, the public sector and more. Read about it, and the EU’s actions, in our latest newsletter:
▶ https://op.europa.eu/en/newsletter
🐦🔗: https://n.respublicae.eu/EMA_News/status/1639185290785873920
#COVID19vaccines: Where do we stand?
✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5
✅ 2 marketing authorisation applications under review
#VaccinesWork #UnitedinProtection
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638812833461977089
To find out more about the progress made in advancing regulatory #science in the 🇪🇺, read our report on the mid-term achievements of the Regulatory Science Strategy to 2025.
➡️https://www.ema.europa.eu/en/news/advancing-regulatory-science-eu-mid-point-report-published
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638526725876219906
In 2022, we approved a new #dengue #vaccine to be used in the European Union and in low-and middle-income countries #LMIC.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638140790923771906
In 2020, we endorsed a vaginal ring to reduce the risk of #HIV infection in women, especially in #Africa.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638140787140571137
In 2016, we gave a positive opinion for the first ever #malaria #vaccine.
Watch the video with Martin Harvey, EMA’s Head of International Affairs, to find out more.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638140782568697857
#DYK that at EMA we also assess vaccines and medicines to be used outside of the EU 🇪🇺?
Find out more about the #EUM4all scheme and our contribution to #globalhealth with @WHO.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1638140777959129090
RT @WHO_Europe: Incorrect interpretations of health information can have serious consequences, from harming #mentalHealth to increasing vaccine hesitancy & delaying necessary healthcare.
Let's prioritize high #QualityHealthInfoOnline & communication to protect ourselves and our communities.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1637731561930981376
📢 The highlights of the Management Board meeting are now available.
Read more about
➡️the Agency’s additional responsibilities as part of its extended mandate
➡️the recent operational experience with the #clinicaltrials information system (#CTIS).
👉https://www.ema.europa.eu/en/news/ema-management-board-highlights-march-2023-meeting
🐦🔗: https://n.respublicae.eu/EMA_News/status/1636750775446536194
EMA's #safety committee, the #PRAC, carried out its work to assess all aspects of risk management related to the use of #medicines.
More information in our meeting highlights: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-13-16-march-2023
🐦🔗: https://n.respublicae.eu/EMA_News/status/1636691621998673920
RT @ECDC_EU: #JustPublished!
#ECDC's overview of recent cases of #botulism in Europe, linked to weight loss medical interventions performed in Türkiye.
Read more ⬇️⬇️⬇️
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635671500018577409
RT @SKyriakidesEU: The Medical Devices Regulation was introduced with a clear goal ➡️to increase the safety of 🇪🇺 patients.
Thanks to the support of Member States, we will ensure that shortages are avoided, and essential medical devices are available at all times for patients.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635643543350919168
RT @SandraGallina: The pandemic made it clearer than ever: we must all work closer together
Today, we have signed new working arrangements with @EC_HERA, @ECDC_EU & @EMA_News on health emergency preparedness & medical countermeasures to increase cooperation and coordination
#HealthUnion
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635581168971141123
RT @EC_HERA: HERA & @ECDC_EU, as well as HERA & @EMA_News have agreed to strengthen cooperation & coordination in health emergency preparedness and response.
All will exchange info on threat assessment, advanced R&D and other priorities for medical countermeasures
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635579282532495361
RT @EC_HERA: HERA’s work continues on preparedness for health threats, including #AvianInfluenza.
HERA laboratory network, through DURABLE, is providing high quality scientific info.
HERA has 2 joint procurement reservation contracts to purchase pandemic influenza vaccines.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635553721739276290
RT @GasteinForum: ⏰ Start the countdown - less than 30 minutes until our hybrid event "Revision of the EU general pharmaceutical legislation" organised in cooperation with @bmsgpk and @AustriaatEU.
Join the discussion online via 👉 https://us06web.zoom.us/j/88099714403
#PharmaLegislation #EUPharmaStrategy
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635324338156208128
RT @calhi415: A healthier 🇪🇺 Europe means healthy 👨👩👧👦citizens and healthy 🥗🍅🍗 #safefood. Working together under the #onehealth approach @EFSA_EU and @EMA_News can help achieve this goal. Thanks for an amazing day discussing how to further this collaboration. Let's continue the work!💪
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635212659007328257
RT @ECDC_Flu: Seasonal #influenza activity had been decreasing across the Region after a peak at week 51/2022 until week 4/2023 and increased again up to week 7/2023 due to increased type B virus circulation.
See more in our infographic below ⬇️⬇️⬇️
and https://flunewseurope.org/
🐦🔗: https://n.respublicae.eu/EMA_News/status/1635212205833719811
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.